Weinander R, Ekström L, Andersson C, Raza H, Bergman T, Morgenstern R
Institute of Environmental Medicine, Division of Biochemical Toxicology, Karolinska Institutet, Box 210, S-171 77 Stockholm, Sweden.
J Biol Chem. 1997 Apr 4;272(14):8871-7. doi: 10.1074/jbc.272.14.8871.
Rat liver microsomal glutathione transferase is rapidly inactivated upon treatment with the arginine-selective reagent phenylglyoxal or the lysine-selective 1,3,5-trinitrobenzenesulfonate. Glutathione sulfonate, an inhibitor of the enzyme, gives nearly complete protection against inactivation and prevents modification, indicating that these residues form part of or reside close to the active site. Sequence analysis of peptides from peptic and tryptic digests of [7-14C]phenylglyoxal- and 1,3,5-trinitrobenzenesulfonate-treated microsomal glutathione transferase indicated arginine 107 and lysine 67 as the sites of modification. A set of mutant forms of microsomal glutathione transferase was constructed by site-directed mutagenesis and heterologously expressed in Escherichia coli BL21(DE3). Arginine 107 was exchanged for alanine and lysine residues. The alanine mutant (R107A) exhibited an activity and inhibition profile similar to that of the wild type enzyme but displayed a decreased thermostability. Thus, arginine 107 does not appear to participate in catalysis or substrate binding; instead, an important structural role is suggested for this residue. Lysine 67 was mutated to alanine and arginine with no effect on activity. All three histidines were replaced by glutamine, and the resulting mutant proteins had activities comparable with that of the wild type. It can thus be concluded that the chemical modification experiments indicating that arginine 107, lysine 67, and one of the histidines partake in catalysis can be disproved. However, protection from modification by a competitive inhibitor indicates that these residues could be close to the glutathione binding site. All tyrosine to phenylalanine substitutions resulted in mutants with activities similar to that of the wild type. Interestingly, the exchange of tyrosine 137 appears to result in activation of the enzyme. Thus, the microsomal glutathione transferase must display an alternate stabilization of the thiolate anion of glutathione other than through interaction with the phenolic hydroxyl group of a tyrosine residue. Substitution of cysteine 49 with alanine resulted in a semiactivated mutant enzyme with enzymatic properties partly resembling the activated form of microsomal glutathione transferase. The function of this mutant was not altered upon reaction with N-ethylmaleimide, and cysteine 49 is thus demonstrated as the site of modification that results in activation of microsomal glutathione transferase.
用精氨酸选择性试剂苯乙二醛或赖氨酸选择性试剂1,3,5-三硝基苯磺酸处理大鼠肝脏微粒体谷胱甘肽转移酶后,该酶会迅速失活。谷胱甘肽磺酸酯作为该酶的抑制剂,几乎能完全保护其免受失活影响并防止修饰,这表明这些残基构成活性位点的一部分或位于其附近。对经[7-¹⁴C]苯乙二醛和1,3,5-三硝基苯磺酸处理的微粒体谷胱甘肽转移酶的胃蛋白酶和胰蛋白酶消化产物的肽段进行序列分析,表明精氨酸107和赖氨酸67是修饰位点。通过定点诱变构建了一组微粒体谷胱甘肽转移酶的突变形式,并在大肠杆菌BL21(DE3)中进行异源表达。将精氨酸107替换为丙氨酸和赖氨酸残基。丙氨酸突变体(R107A)表现出与野生型酶相似的活性和抑制谱,但热稳定性降低。因此,精氨酸107似乎不参与催化或底物结合;相反,该残基具有重要的结构作用。赖氨酸67突变为丙氨酸和精氨酸对活性无影响。所有三个组氨酸都被谷氨酰胺取代,所得突变蛋白的活性与野生型相当。因此可以得出结论,表明精氨酸107、赖氨酸67和其中一个组氨酸参与催化的化学修饰实验可被推翻。然而,竞争性抑制剂对修饰的保护作用表明这些残基可能靠近谷胱甘肽结合位点。所有酪氨酸到苯丙氨酸的替换都产生了与野生型活性相似的突变体。有趣的是,酪氨酸137的替换似乎导致酶的激活。因此,微粒体谷胱甘肽转移酶必须表现出谷胱甘肽硫醇阴离子的另一种稳定方式,而不是通过与酪氨酸残基的酚羟基相互作用。将半胱氨酸49替换为丙氨酸产生了一种部分激活的突变酶,其酶学性质部分类似于微粒体谷胱甘肽转移酶的激活形式。该突变体与N-乙基马来酰亚胺反应后功能未改变,因此半胱氨酸49被证明是导致微粒体谷胱甘肽转移酶激活的修饰位点。